The Drug Maker Who Wouldn't Shoot Straight

Can clever marketing sell an expensive Alzheimer's drug that doesn't work?

Photo by National Cancer Institute on Unsplash

There’s good news and bad news in the quest for Alzheimer’s Disease treatments. The good news is that the Food and Drug Administration (FDA) approved a new drug for Alzheimer’s in June, the first new treatment for the disease in nearly two decades. The bad news is that there is no convincing proof that the d…